RenovoRx, Inc. (RNXT)
1.275
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 12:00
RenovoRx Price : 1.275 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 1.32 | 1.35 | 1.25 | 1.28 | 798789.0 |
| Oct 08, 2026 | 1.33 | 1.37 | 1.31 | 1.33 | 438650.0 |
| Oct 07, 2026 | 1.35 | 1.41 | 1.275 | 1.37 | 594618.0 |
| Oct 06, 2026 | 1.51 | 1.57 | 1.37 | 1.39 | 621683.0 |
| Oct 05, 2026 | 1.58 | 1.61 | 1.43 | 1.47 | 618033.0 |
| Oct 02, 2026 | 1.57 | 1.61 | 1.55 | 1.58 | 269370.0 |
| Oct 01, 2026 | 1.57 | 1.59 | 1.500 | 1.55 | 404025.0 |
| Sep 30, 2026 | 1.57 | 1.64 | 1.54 | 1.56 | 397957.0 |
| Sep 29, 2026 | 1.57 | 1.59 | 1.51 | 1.57 | 370919.0 |
| Sep 28, 2026 | 1.65 | 1.65 | 1.50 | 1.55 | 877001.0 |
| Sep 25, 2026 | 1.69 | 1.725 | 1.645 | 1.66 | 490854.0 |
| Sep 24, 2026 | 1.61 | 1.70 | 1.53 | 1.68 | 630067.0 |
| Sep 23, 2026 | 1.70 | 1.800 | 1.60 | 1.63 | 765010.0 |
| Sep 22, 2026 | 1.70 | 1.73 | 1.67 | 1.70 | 383948.0 |
| Sep 21, 2026 | 1.69 | 1.74 | 1.630 | 1.67 | 482554.0 |
| Sep 18, 2026 | 1.74 | 1.75 | 1.67 | 1.69 | 566879.0 |
| Sep 17, 2026 | 1.60 | 1.77 | 1.58 | 1.73 | 636082.0 |
| Sep 16, 2026 | 1.73 | 1.73 | 1.55 | 1.55 | 1.036M |
| Sep 15, 2026 | 1.692 | 1.73 | 1.60 | 1.72 | 1.033M |
| Sep 14, 2026 | 1.75 | 1.85 | 1.66 | 1.69 | 579669.0 |
| Sep 11, 2026 | 1.77 | 1.820 | 1.67 | 1.76 | 1.168M |
| Sep 10, 2026 | 1.97 | 1.99 | 1.71 | 1.77 | 1.641M |
| Sep 09, 2026 | 2.15 | 2.30 | 1.935 | 1.995 | 1.734M |
| Sep 08, 2026 | 2.31 | 2.345 | 2.151 | 2.20 | 1.207M |
| Sep 04, 2026 | 2.35 | 2.540 | 2.28 | 2.39 | 2.092M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 12.27 |
| Travere Therapeutics, Inc. | 52.68 |
| REGENXBIO, Inc. | 8.08 |
| Krystal Biotech, Inc. | 332.14 |
| ACADIA Pharmaceuticals, Inc. | 19.60 |
Price Related Metrics
| PS Ratio | 25.58 |
| Price to Book Value | 6.407 |
| Earnings Yield | -24.63% |
| Market Cap | 57.53M |